BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17053475)

  • 1. Plasmapheresis in nephrology: an update.
    Rahman T; Harper L
    Curr Opin Nephrol Hypertens; 2006 Nov; 15(6):603-9. PubMed ID: 17053475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
    Gaskin G; Pusey CD
    Ther Apher; 2001 Jun; 5(3):176-81. PubMed ID: 11467753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of plasmapheresis in immunological kidney diseases. Experience from 1050 completed plasmapheresis treatment sessions].
    Haris A; Arányi J; Braunitzer H; Kálmán E; Merán Z; Soltész M; Polner K
    Orv Hetil; 2011 Jul; 152(28):1110-9. PubMed ID: 21712172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis.
    Jayne DR; Gaskin G; Rasmussen N; Abramowicz D; Ferrario F; Guillevin L; Mirapeix E; Savage CO; Sinico RA; Stegeman CA; Westman KW; van der Woude FJ; de Lind van Wijngaarden RA; Pusey CD;
    J Am Soc Nephrol; 2007 Jul; 18(7):2180-8. PubMed ID: 17582159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-filtration plasmapheresis.
    Tanabe K
    Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange for renal disease: evidence and use 2011.
    Clark WF
    J Clin Apher; 2012; 27(3):112-6. PubMed ID: 22535650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis in immunologic renal disease.
    Pusey CD; Levy JB
    Blood Purif; 2012; 33(1-3):190-8. PubMed ID: 22269818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Which patients should be treated with plasma exchange? Indications for plasma exchange therapy].
    Cala S
    Lijec Vjesn; 1996; 118(11-12):286-90. PubMed ID: 9213718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic plasma exchange in systemic vasculitis: an update on indications and results.
    Mahr A; Chaigne-Delalande S; De Menthon M
    Curr Opin Rheumatol; 2012 May; 24(3):261-6. PubMed ID: 22456283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allografts.
    Sivakumaran P; Vo AA; Villicana R; Peng A; Jordan SC; Pepkowitz SH; Klapper EB
    J Clin Apher; 2009; 24(4):155-60. PubMed ID: 19658162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Japan's experience with living-donor kidney transplantation across ABO barriers.
    Ichimaru N; Takahara S
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):682-92. PubMed ID: 18941430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic apheresis for renal disorders.
    Sanchez AP; Ward DM
    Semin Dial; 2012; 25(2):119-31. PubMed ID: 22428811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant immunosuppression in highly sensitized patients.
    Akalin E
    Contrib Nephrol; 2009; 162():27-34. PubMed ID: 19001811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization strategies enabling successful renal transplantation in highly sensitized patients.
    Beimler JH; Susal C; Zeier M
    Clin Transplant; 2006; 20 Suppl 17():7-12. PubMed ID: 17100695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab.
    Chikaraishi T; Sasaki H; Tsutsumi H; Miyano S; Nakazawa R; Nakano T; Kitajima K; Kudo H; Takahashi T; Sato Y; Kimura K
    Transplant Proc; 2008 Dec; 40(10):3445-7. PubMed ID: 19100409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal transplantation in patients with positive lymphocytotoxicity crossmatches: one center's experience.
    Magee CC; Felgueiras J; Tinckam K; Malek S; Mah H; Tullius S
    Transplantation; 2008 Jul; 86(1):96-103. PubMed ID: 18622284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic plasma exchange: a review of the literature].
    Andrulli S; Bigi MC; Granata A; Cossu M; Logias F
    G Ital Nefrol; 2012; 29 Suppl 54():S40-8. PubMed ID: 22388829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.